Taco Bell's side of the lettuce mess has been the easy part to admire; move fast, stay narrow, let the CEO post gratitude instead of grievance. The company pulled every affected Taylor Farms lettuce product from every US restaurant "within 72 hours" and left the science to the scientists.

Its supplier, Taylor Farms, the company federal investigators actually named in the traceback, went the other way, and so much of it was avoidable. Of course, those two were never playing the same hand. Taco Bell could swap a supplier and walk away; Taylor Farms had its name in the traceback and couldn't. Which is the first thing to get straight in any crisis, not what to say, but what you are in it. Named party, customer, target, bystander. That's what decides whether silence is even on the menu, and Taylor Farms never had that option. On July 19, Taylor Farms issued a statement and posted on social that the FDA had apologized to it after a lettuce sample flagged for cyclospora turned out to be a false positive. "Today, FDA apologized to us," the post read, adding that the agency had "not identified a single positive product test result."

That was the misstep, because a company can't just declare itself off the hook and have it stick. Within a day the FDA told reporters, plainly, "We did not offer an official apology, but did explain factually the issues," and HHS said the same. The agency went further, saying the false positive changed nothing about the "overwhelming epidemiological data", the pattern of who got sick and what they'd eaten, still pointing at Taylor Farms lettuce. And the "no positive test" line the company leaned on didn't hold either: a former deputy FDA commissioner explained that cyclospora is so hard to detect in food that the absence of a positive sample clears precisely nobody. So Taylor Farms built its comeback on a fact that sounds exculpatory to a general audience but also means very little to anyone who knows how this parasite behaves.

From there it got worse the way these things do, by looking like the company was working the refs instead of the problem. Execs had met White House and FDA officials on July 16, the day before the recall, and had recently hired a former White House official; so when the apology claim collapsed, critics pulled that thread hard, surfacing a $1 million donation the company made to a pro-Trump super PAC and the timing of a delayed food-traceability rule. There's no evidence any of that changed the FDA's handling but that's almost beside the point, because the accusation is now the story and Taylor Farms had pretty much supplied the opening.

For anyone who might one day be the person standing between their company and a regulator: recalling a product and denying you did anything wrong, in the same breath, is really just a company arguing with itself in public. And that urge to push back on the regulator is strongest right when you're the one with your name on the outbreak and the most to lose, which is exactly when pushing back does the most damage. The trap is an executive wanting to take something true that helps you and stretch it a little further than the regulator will back up. The FDA told Taylor Farms it had made a testing error; they told the world the FDA apologized. The FDA cleared one sample; they said the whole company was in the clear. So when a regulator gives you good news, repeat exactly what they said and not a word more, because they'll correct the difference in public, and that correction turns into the headline.

The question Taylor Farms still hasn't answered is the only one that matters: is the lettuce safe, and how would anyone actually know?

Last September, Samsung Electronics America threw a grand opening for its new US headquarters, a "state-of-the-art" campus in Englewood Cliffs, New Jersey, the old Unilever building on Sylvan Avenue, with room for around 1,200 people and local officials on hand to celebrate what they called a long-term commitment to the state. Eight months later, in June, Samsung announced it was moving that headquarters to an existing campus in Plano, Texas, by year's end. This month, a WARN notice covering 739 employees in Englewood Cliffs who are being laid off or offered a move to Texas, effective September 30, with at least another 100 jobs going in Plano. The company's explanation, in the email staff received, was that all of it is happening "as part of our business transformation."

Let's read that again: "business transformation" is describing two very ordinary things: moving an office fifteen hundred miles, and cutting a big chunk of the people in the one you just opened. When you use language that fuzzy, it's usually because the plain version ("we changed our minds about New Jersey and your job is the price") is the one it can't bring itself to say. The trouble is that everyone can do that translation on their own, and the vaguer the official wording, the more people believe their own read over yours.

A good reminder for all of us is that a ribbon-cutting is a promise. When you throw a grand opening and you throw around the "state-of-the-art" adjectives, the headcount, the officials at the podium, you're spending real trust to tell employees and a town that you're here to stay. Undo that inside a year and you've made the next promise harder to believe. And none of this is a mystery inside the building, the consumer-electronics side doing the cutting is the same Samsung whose chip business just posted quarterly profit up nearly twentyfold on AI demand.

If you're the one who'll get handed the happy version to write, the opening, the "we're all in on this city," the jobs number, the smart instinct is to treat that announcement as a forecast you'll be measured against, and to push, diplomatically, on how solid the commitment really is before you put big scissors and a podium behind it. The applause is cheap; the reversal is what people remember. So when the plan might not outlast the press release, what are you really promising at that ribbon-cutting and who pays for it if you're wrong?